Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

13

Number of overlapping holdings

54.2%

% of PJP's 24 holdings also in XPH

35.1%

% of XPH's 40 holdings also in PJP

Overlap by Weight
Sector Drift (PJP minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PJP
Weight
in XPH
Overlap
ELI LILLY & CO 6.0% 5.6% 5.6%
MERCK & CO. INC. 5.8% 4.2% 4.2%
JOHNSON & JOHNSON 5.6% 4.0% 4.0%
PFIZER INC 5.4% 3.8% 3.8%
JAZZ PHARMACEUTICALS PLC 3.3% 4.5% 3.3%

Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to XPH
ABBVIE INC 6.0%
AMGEN INC 5.9%
GILEAD SCIENCES INC 5.8%
ABBOTT LABORATORIES 5.6%
TRAVERE THERAPEUTICS, INC. 3.7%
VALEANT PHARMACEUTICALS INT'L 3.6%
TARO PHARMACEUTICAL INDUS 3.6%
REGENERON PHARMACEUTICALS 3.4%
GERON CORP 3.4%
BIOGEN IDEC INC 3.4%
PJP Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A -7.9%
ELANCO ANIMAL HEALTH, INC. -5.7%
CATALENT INC -5.5%
ZOETIS INC -4.8%
VIATRIS, INC. -4.5%
AXSOME THERAPEUTICS, INC. -4.4%
BRISTOL-MYERS SQUIBB CO -3.9%
ORGANON & CO. -3.8%
ROYALTY PHARMA PLC CLASS A -3.7%
INTRA-CELLULAR THERAPIES INC -3.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY